| Autor: |
Thu M; Department of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Japan. ohtsuk@okayama-u.ac.jp., Yanai K; Department of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Japan. ohtsuk@okayama-u.ac.jp., Shigeto H; Health and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 2217-14 Hayashi-cho, Takamatsu, Kagawa 761-0395, Japan., Yamamura S; Health and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 2217-14 Hayashi-cho, Takamatsu, Kagawa 761-0395, Japan., Watanabe K; Department of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Japan. ohtsuk@okayama-u.ac.jp., Ohtsuki T; Department of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Japan. ohtsuk@okayama-u.ac.jp. |
| Abstrakt: |
Technologies for visualizing and tracking RNA are essential in molecular biology, including in disease-related fields. In this study, we propose a novel probe set (DAt-probe and T-probe) that simultaneously detects two mutations in the same RNA using fluorescence resonance energy transfer (FRET). The DAt-probe carrying the fluorophore Atto488 and the quencher Dabcyl were used to detect a cancer mutation (exon19del), and the T-probe carrying the fluorophore Tamra was used to detect drug resistance mutations (T790M) in epidermal growth factor receptor ( EGFR ) mRNA. These probes were designed to induce FRET when both mutations were present in the mRNA. Gel electrophoresis confirmed that the two probes could efficiently bind to the mutant mRNA. We measured the FRET ratios using wild-type and double-mutant RNAs and found a significant difference between them. Even in living cells, the FRET probe could visualize mutant RNA. As a result, we conclude that this probe set provides a method for detecting two mutations in the single EGFR mRNA via FRET. |
